Baudax Bio, Inc.

NASDAQ (USD): Baudax Bio, Inc. (BXRX)

Last Price

0.022

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Overview

Market Cap

950,330

Shares Outstanding

43 Million

Avg Volume

424,847

Avg Price (50 Days)

0.02

Avg Price (200 Days)

0.29

PE Ratio

-0.00

EPS

-94.13

Earnings Announcement

10-May-2024

Previous Close

0.02

Open

0.02

Day's Range

0.02 - 0.022025

Year Range

0.0137 - 3.4699

Trading Volume

310,872

Price Change Highlight

1 Day Change

0.00%

5 Day Change

24.57%

1 Month Change

0.00%

3 Month Change

-0.91%

6 Month Change

-94.11%

Ytd Change

-8.02%

1 Year Change

-98.73%

3 Year Change

-100.00%

5 Year Change

-100.00%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment